Dr. Guenther Koehne, MD, PhD
Claim this profileMiami Cancer Institute
Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
11 reported clinical trials
20 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
CD33 positive
FLT3 positive
2Acute Myeloid Leukemia
CD33 positive
FLT3 positive
Affiliated Hospitals
Clinical Trials Guenther Koehne, MD, PhD is currently running
Cell Therapy
for Non-Hodgkin's Lymphoma
This trial tests a new treatment where a patient's own immune cells are enhanced to fight difficult-to-treat lymphoma. It targets patients whose cancer hasn't responded to at least two other treatments. The modified cells aim to better recognize and attack the cancer. This new method improves the ability of the patient's immune cells to find and destroy cancer cells.
Recruiting1 award Phase 219 criteria
Iadademstat + Gilteritinib
for Acute Myeloid Leukemia
Iadademstat is being studied as a treatment for subjects with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) with FMS-like tyrosine kinase mutation (FLT3 mut+). During the trial, iadademstat will be given in combination with gilteritinib, a drug that is already approved to treat patients with FLT3-mutated R/R AML.
Recruiting1 award Phase 1
More about Guenther Koehne, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Guenther Koehne, MD, PhD has experience with
- VOR33
- CD34+ Transplants
- Placebo
- LY3832479
- LY3853113
- LY3819253
Breakdown of trials Guenther Koehne, MD, PhD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Leukemia
Coronavirus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Guenther Koehne, MD, PhD specialize in?
Guenther Koehne, MD, PhD focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved CD33 positive patients, or patients who are FLT3 positive.
Is Guenther Koehne, MD, PhD currently recruiting for clinical trials?
Yes, Guenther Koehne, MD, PhD is currently recruiting for 2 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Guenther Koehne, MD, PhD has studied deeply?
Yes, Guenther Koehne, MD, PhD has studied treatments such as VOR33, CD34+ Transplants, Placebo.
What is the best way to schedule an appointment with Guenther Koehne, MD, PhD?
Apply for one of the trials that Guenther Koehne, MD, PhD is conducting.
What is the office address of Guenther Koehne, MD, PhD?
The office of Guenther Koehne, MD, PhD is located at: Miami Cancer Institute, Miami, Florida 33176 United States. This is the address for their practice at the Miami Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.